Government Plans Strict Control Over Medicines Containing Alcohol

The government has proposed bringing several alcohol-based medicinal products under Schedule H1. The move aims to prevent misuse while ensuring patients continue to access genuine treatment.

If approved, Medicines Containing Alcohol will require a valid doctor's prescription and stricter monitoring at pharmacies.

The proposal was cleared by expert committees under the Central Drugs Standard Control Organisation (CDSCO). It seeks to stop the misuse of medicinal products that contain high amounts of alcohol. These products are sometimes used for intoxication instead of medical treatment. The new rules are expected to improve accountability in the supply chain.

What Will Change Under Schedule H1?

The government has proposed shifting medicinal preparations containing Schedule H1 under stricter regulatory control. Products containing 30 ml or more of alcohol may be covered by the new rule.

If the proposal is implemented:

• A valid prescription from a registered medical practitioner will be mandatory.
• Pharmacies must maintain a separate register for every sale.
• The register will include the patient's name, doctor's details, medicine, and quantity sold.
• Records must be preserved for official inspection.
• Medicine labels will carry a clear warning against sale without a prescription.

These measures are designed to prevent unauthorized purchases and improve monitoring.

Also Read: The Strategic Role of Regional Corridors in Future-Ready MedTech

Why Is the Government Tightening the Rules?

Officials believe some alcohol-containing medicinal products are being misused as substitutes for alcoholic beverages. This has raised concerns about public health and illegal sales.

The proposal aims to:

• Reduce misuse of alcohol-based medicinal products.
• Prevent over-the-counter sales without medical advice.
• Strengthen monitoring of medicine distribution.
• Increase accountability for manufacturers and pharmacies.

The expert committees recommended stricter controls after reviewing the issue. The proposal has now moved forward as part of the regulatory process.

Will Patients Still Get These Medicines?

The proposed rule is not a ban on these medicines. Patients with genuine medical needs can continue buying them with a valid prescription.

The change mainly affects how pharmacies sell and record these products. It also increases oversight to ensure medicines are used only for medical purposes.

If implemented, pharmacies across India will need to follow Schedule H1 requirements while dispensing these products. The government believes the move will help curb misuse without affecting patients who rely on these medicines for treatment.

As of now, the proposal awaits further regulatory action before becoming effective. Once notified, pharmacies and healthcare providers will need to comply with the revised rules.